Cargando…

H3G34-Mutant Gliomas—A Review of Molecular Pathogenesis and Therapeutic Options

The 2021 World Health Organization Classification of Tumors of the Central Nervous System reflected advances in understanding of the roles of oncohistones in gliomagenesis with the introduction of the H3.3-G34R/V mutant glioma to the already recognized H3-K27M altered glioma, which represent the dia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, Anthony V., Soto, Jose M., Gonzalez, Sarah-Marie, Murillo, Jennifer, Trumble, Eric R., Shan, Frank Y., Huang, Jason H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377039/ https://www.ncbi.nlm.nih.gov/pubmed/37509641 http://dx.doi.org/10.3390/biomedicines11072002

Ejemplares similares

MPC-5 Characteristics of H3 G34-mutant gliomas
por: Kibe, Yuji, et al.
Publicado: (2021)

Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults
por: Picart, Thiébaud, et al.
Publicado: (2021)

SDPS-08 OSSEOUS METASTASES IN H3G34-MUTANT DIFFUSE HEMISPHERIC GLIOMAS
por: Yu, Nina, et al.
Publicado: (2023)

Systematic review of diffuse hemispheric glioma, H3 G34-mutant: Outcomes and associated clinical factors
por: Crowell, Cameron, et al.
Publicado: (2022)

Pediatric diffuse hemispheric glioma H3 G34-mutant with gains of the BRAF locus: An illustrative case
por: Marlow, Christine, et al.
Publicado: (2023)

MPC-7 Clinical features of Diffuse hemispheric glioma, H3 G34-mutant in children and young adults
por: Takeshima, Yuki, et al.
Publicado: (2021)

H3G34-mutant diffuse hemispheric glioma with osseous metastases: a case report and literature review
por: Yu, Nina, et al.
Publicado: (2023)

IMMU-04. TARGETING ALTERNATIVE SPLICING VARIANTS TO STIMULATE ANTI-TUMOR IMMUNITY IN A NOVEL SYNGENEIC MOUSE MODEL OF DIFFUSE HEMISPHERIC GLIOMA, H3 G34-MUTANT
por: Owens, Geoffrey, et al.
Publicado: (2023)

HGG-05. Systematic review of diffuse hemispheric glioma, H3 G34-mutant and clinical factors influencing outcomes
por: Crowell, Cameron, et al.
Publicado: (2022)

Imaging features associated with H3 K27-altered and H3 G34-mutant gliomas: a narrative systematic review
por: Lasocki, Arian, et al.
Publicado: (2022)

Diffuse hemispheric glioma, H3 G34-mutant: Genomic landscape of a new tumor entity and prospects for targeted therapy
por: Lucas, Calixto-Hope G, et al.
Publicado: (2021)

HGG-44. Unraveling and Targeting the stem-regulatory network driving invasion in Diffuse hemispheric glioma, H3G34-mutant
por: Palma, Alessandro, et al.
Publicado: (2022)

New Developments in the Pathogenesis, Therapeutic Targeting, and Treatment of H3K27M-Mutant Diffuse Midline Glioma
por: Argersinger, Davis P., et al.
Publicado: (2021)

Mutant IDH in Gliomas: Role in Cancer and Treatment Options
por: Solomou, Georgios, et al.
Publicado: (2023)

High frequency of PDGFRA and MUC family gene mutations in diffuse hemispheric glioma, H3 G34-mutant: a glimmer of hope?
por: Hu, Wanming, et al.
Publicado: (2022)

Case Report: Evolutionary Clinical-Radiological Features of a Diffuse Hemispheric Glioma, H3 G34 Mutant with Over 5 Years of Survival
por: Yamada, Camilla A.F., et al.
Publicado: (2023)

STINGing the immune system: lessons learned through a model of G34-mutant pediatric high-grade glioma
por: Hall, Connor P., et al.
Publicado: (2022)

HGG-05. PERTURBING GABAERGIC NEURONAL LINEAGE IN DIFFUSE HEMISPHERIC GLIOMA, H3G34-MUTANT, HIGHLIGHTS CDK6 AS A CLINICALLY ACTIONABLE TARGET
por: Liu, Ilon, et al.
Publicado: (2023)

Base-resolution methylomes of gliomas bearing histone H3.3 mutations reveal a G34 mutant-specific signature shared with bone tumors
por: Sangatsuda, Yuhei, et al.
Publicado: (2020)

Acquired facial lipoatrophy: pathogenesis and therapeutic options
por: Szczerkowska-Dobosz, Aneta, et al.
Publicado: (2015)

TBIO-08. BASE-RESOLUTION METHYLOMES OF GLIOMAS BEARING HISTONE H3.3 MUTATIONS REVEAL A G34 MUTANT-SPECIFIC SIGNATURE SHARED WITH BONE TUMORS
por: Sangatsuda, Yuhei, et al.
Publicado: (2020)

Utility of arterial spin labeling for objective assessment of intratumoral microvessels in diffuse hemispheric glioma, H3 G34R-mutant: A case report and literature review
por: Kitakami, Kei, et al.
Publicado: (2022)

Extraneural Metastases From a High-Grade Glioma (HGG) With an H3F3A G34R Mutation
por: Jethanandani, Amit, et al.
Publicado: (2019)

HGG-26. H3G34V MUTATION AFFECTS GENOMIC H3K36 METHYLATION IN PEDIATRIC GLIOMA
por: Huang, Tina, et al.
Publicado: (2020)

Targeting therapeutic vulnerabilities with PARP inhibition and radiation in IDH-mutant gliomas and cholangiocarcinomas
por: Wang, Yuxiang, et al.
Publicado: (2020)

A review on surgical treatment options in gliomas
por: Yang, Zhongxi, et al.
Publicado: (2023)

Clostridium difficile Infection: Epidemiology, Pathogenesis, Risk Factors, and Therapeutic Options
por: Goudarzi, Mehdi, et al.
Publicado: (2014)

Neutropenia and Large Granular Lymphocyte Leukemia: From Pathogenesis to Therapeutic Options
por: Calabretto, Giulia, et al.
Publicado: (2021)

Editorial: Endocrine Diseases of Newborn: Epidemiology, Pathogenesis, Therapeutic Options and Outcome
por: Midgley, Paula Caroline, et al.
Publicado: (2021)

Significance of Histone H3.3 (G34W)-Mutant Protein in Pathological Diagnosis of Giant Cell Tumor of Bone
por: Miskad, Upik A, et al.
Publicado: (2023)

HGG-06. EARLY GABAERGIC NEURONAL LINEAGE DEFINES DEPENDENCIES IN HISTONE H3 G34R/V GLIOMA
por: Liu, Ilon, et al.
Publicado: (2021)

Globally altered epigenetic landscape and delayed osteogenic differentiation in H3.3-G34W-mutant giant cell tumor of bone
por: Lutsik, Pavlo, et al.
Publicado: (2020)

Oncolytic immunovirotherapy for high-grade gliomas: A novel and an evolving therapeutic option
por: Asija, Sweety, et al.
Publicado: (2023)

Congenital Hypopituitarism During the Neonatal Period: Epidemiology, Pathogenesis, Therapeutic Options, and Outcome
por: Bosch i Ara, Laura, et al.
Publicado: (2021)

Reviewing the role of gut microbiota in the pathogenesis of depression and exploring new therapeutic options
por: Han, Wenjie, et al.
Publicado: (2022)

Role of Histone Deacetylases in the Pathogenesis of Salivary Gland Tumors and Therapeutic Targeting Options
por: Manou, Maria, et al.
Publicado: (2023)

Molecular Heterogeneity in BRAF-Mutant Gliomas: Diagnostic, Prognostic, and Therapeutic Implications
por: Lhermitte, Benoit, et al.
Publicado: (2023)

New Developments in the Pathogenesis and Therapeutic Targeting of the IDH1 Mutation in Glioma
por: Dimitrov, Lilia, et al.
Publicado: (2015)

Personalized Treatment of H3K27M-Mutant Pediatric Diffuse Gliomas Provides Improved Therapeutic Opportunities
por: Gojo, Johannes, et al.
Publicado: (2020)

H3F3A-G34R mutant high grade neuroepithelial neoplasms with glial and dysplastic ganglion cell components
por: Andreiuolo, Felipe, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_600r7ldiv1aj1bg32pbmh59bqb